PATENT CLAIM ANALYSIS

Application Number: 16072686
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-06
Patent Classification: ["514", "471000"]

Abstract:
The use of an NLRP3 inhibitor compound is described in the treatment of inflammatory skin disorders, in particular psoriasis and atopic dermatitis.

Claim (Index 16):
The method of claim  1 , wherein the halogen is a chlorine or fluorine.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 99.0
- Lexical Diversity: 1.09091
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15551264', '14380078', '12992766', '10559322', '12937006']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7641821580754217
- 35 USC 102 Novelty (BERT): 0.5126446828238916
- Combined Prediction Score: 0.7390284105502687
- Mean Citation Score: 225.059508
- Max Citation Score: 256.63382
- Similarity Product: 161.9946900086689

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test